Results 221 to 230 of about 33,626 (230)

Donepezil-based multi-functional cholinesterase inhibitors for treatment of Alzheimer's disease

European Journal of Medicinal Chemistry, 2018
Yao Chen, Wei Qu
exaly  

Donepezil + propargylamine + 8-hydroxyquinoline hybrids as new multifunctional metal-chelators, ChE and MAO inhibitors for the potential treatment of Alzheimer's disease

European Journal of Medicinal Chemistry, 2014
Li Wang, Gerard Esteban, Tsutomu Inokuchi   +2 more
exaly  

In vitro and in vivo evaluation of donepezil-sustained release microparticles for the treatment of Alzheimer's disease

Biomaterials, 2007
Pengcheng Zhang, Zheng-Hong Xu
exaly  

Donepezil inhibits the amyloid-beta oligomer-induced microglial activation in vitro and in vivo

NeuroToxicology, 2014
Hyo Geun Kim, Minho Moon, Gunhyuk Park
exaly  

Controlled release of donepezil intercalated in smectite clays

International Journal of Pharmaceutics, 2008
Jin Kuen Park, Young Bin Choy, Jae-Min Oh   +2 more
exaly  

Donepezil

Reactions Weekly, 2014
openaire   +1 more source

Urinary incontinence: an unrecognised adverse effect with donepezil

Lancet, The, 2000
exaly  

Donepezil, a drug for Alzheimer’s disease, promotes oligodendrocyte generation and remyelination

Acta Pharmacologica Sinica, 2019
Xin Xie
exaly  

Discontinuing Donepezil or Starting Memantine for Alzheimer's Disease

New England Journal of Medicine, 2012
exaly   +2 more sources

Donepezil

Reactions Weekly, 2018
openaire   +1 more source